Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial.

Zaninetti C, Gresele P, Bertomoro A, Klersy C, De Candia E, Veneri D, Barozzi S, Fierro T, Alberelli MA, Musella V, Noris P, Fabris F, Balduini CL, Pecci A.

Haematologica. 2019 Jul 4. pii: haematol.2019.223966. doi: 10.3324/haematol.2019.223966. [Epub ahead of print]

2.

Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review.

Zanon E, Pasca S, Bertomoro A, Mardari R, Simioni P.

Haemophilia. 2019 Jul;25(4):e282-e285. doi: 10.1111/hae.13742. Epub 2019 Mar 29. No abstract available.

PMID:
30924991
3.

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

Peyvandi F, Castaman G, Gresele P, De Cristofaro R, Schinco P, Bertomoro A, Morfini M, Gamba G, Barillari G, Jiménez-Yuste V, Königs C, Iorio A, Federici AB.

Blood Transfus. 2019 Feb 4:1-8. doi: 10.2450/2019.0183-18. [Epub ahead of print]

4.

A 29-year-old woman with persistent thrombocytopenia.

Di Pasquale I, Bertomoro A, Vianello F, Marson P, Boscaro F, Fabris F.

Intern Emerg Med. 2019 Feb 12. doi: 10.1007/s11739-019-02030-6. [Epub ahead of print] No abstract available.

PMID:
30747363
5.

Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.

Di Pasquale I, Budde U, Tona F, Bertomoro A, Lombardi AM, Famoso G, Bertozzi I, Dittmer R, Schneppenheim S, Fabris F.

Thromb Res. 2019 Jan;173:42-47. doi: 10.1016/j.thromres.2018.11.005. Epub 2018 Nov 12.

PMID:
30471507
6.

New heterozygous variant in GP1BB gene is responsible for an inherited form of macrothrombocytopenia.

Ferrari S, Lombardi AM, Cortella I, Businaro MA, Bertomoro A, Di Pasquale I, Fabris F.

Br J Haematol. 2019 Mar;184(5):855-858. doi: 10.1111/bjh.15176. Epub 2018 Mar 12. No abstract available.

PMID:
29527674
7.

Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue.

Casonato A, Daidone V, Galletta E, Bertomoro A.

PLoS One. 2017 Jun 22;12(6):e0179566. doi: 10.1371/journal.pone.0179566. eCollection 2017.

8.

Spectrum of 5'UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected.

Ferrari S, Lombardi AM, Putti MC, Bertomoro A, Cortella I, Barzon I, Girolami A, Fabris F.

Platelets. 2017 Sep;28(6):621-624. doi: 10.1080/09537104.2016.1267337. Epub 2017 Feb 16. No abstract available.

PMID:
28277066
9.

The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.

Daidone V, Galletta E, Bertomoro A, Casonato A.

Blood Transfus. 2018 Jan;16(1):114-117. doi: 10.2450/2016.0132-16. Epub 2016 Nov 15. No abstract available.

10.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Casonato A, Cattini MG, Daidone V, Pontara E, Bertomoro A, Prandoni P.

PLoS One. 2016 Aug 17;11(8):e0161310. doi: 10.1371/journal.pone.0161310. eCollection 2016.

11.

Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.

Colombatti R, De Bon E, Bertomoro A, Casonato A, Pontara E, Omenetto E, Saggiorato G, Steffan A, Damian T, Cella G, Teso S, Manara R, Rampazzo P, Meneghetti G, Basso G, Sartori MT, Sainati L.

PLoS One. 2013 Oct 25;8(10):e78801. doi: 10.1371/journal.pone.0078801. eCollection 2013.

12.

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Daidone V, Gallinaro L, Grazia Cattini M, Pontara E, Bertomoro A, Pagnan A, Casonato A.

Haematologica. 2011 Jun;96(6):881-7. doi: 10.3324/haematol.2010.036848. Epub 2011 Mar 10.

13.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.

Casonato A, Gallinaro L, Cattini MG, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Haematologica. 2010 Aug;95(8):1366-72. doi: 10.3324/haematol.2009.019927. Epub 2010 Mar 19.

14.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

Casonato A, Gallinaro L, Cattini MG, Sartorello F, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Transl Res. 2010 Apr;155(4):200-8. doi: 10.1016/j.trsl.2009.12.003. Epub 2009 Dec 30.

PMID:
20303469
15.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A.

Blood. 2008 Apr 1;111(7):3540-5. doi: 10.1182/blood-2007-11-122945. Epub 2008 Feb 1.

16.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.

Casonato A, Sartorello F, Pontara E, Gallinaro L, Bertomoro A, Grazia Cattini M, Daidone V, Szukowska M, Pagnan A.

Thromb Haemost. 2007 Dec;98(6):1182-7.

PMID:
18064311
17.

Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction.

Bilora F, Zanon E, Casonato A, Bertomoro A, Petrobelli F, Cavraro M, Campagnolo E, Girolami A.

Clin Appl Thromb Hemost. 2007 Oct;13(4):384-90.

PMID:
17911189
18.

Identifying carriers of type 2N von Willebrand disease: procedures and significance.

Casonato A, Pontara E, Sartorello F, Cattini MG, Perutelli P, Bertomoro A, Gallinaro L, Pagnan A.

Clin Appl Thromb Hemost. 2007 Apr;13(2):194-200.

PMID:
17456630
19.

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.

Gallinaro L, Sartorello F, Pontara E, Cattini MG, Bertomoro A, Bartoloni L, Pagnan A, Casonato A.

Thromb Haemost. 2006 Dec;96(6):711-6.

PMID:
17139363
20.

Identifying type Vicenza von Willebrand disease.

Casonato A, Pontara E, Sartorello F, Cattini MG, Gallinaro L, Bertomoro A, Rosato A, Padrini R, Pagnan A.

J Lab Clin Med. 2006 Feb;147(2):96-102.

PMID:
16459168
21.

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.

Casonato A, Pontara E, Bertomoro A, Cattini MG, Soldera C, Girolami A.

Haematologica. 2003 Jun;88(6):688-93.

22.

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

Casonato A, Sartorello F, Cattini MG, Pontara E, Soldera C, Bertomoro A, Girolami A.

Blood. 2003 Jan 1;101(1):151-6. Epub 2002 Aug 8.

23.

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome.

Casonato A, Pontara E, Doria A, Bertomoro A, Cattini MG, Gambari PF, Girolami A.

Br J Haematol. 2002 Mar;116(4):899-904.

PMID:
11886398
24.

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

Casonato A, Pontara E, Bertomoro A, Sartorello F, Cattini MG, Girolami A.

Br J Haematol. 2001 Mar;112(3):578-83.

PMID:
11260057
25.

Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.

Casonato A, Pontara E, Sartorello F, Bertomoro A, Durante C, Girolami A.

J Lab Clin Med. 2001 Jan;137(1):70-6.

PMID:
11150026
26.

Combined factor V and factor VII deficiency due to an independent segregation of the two defects.

Girolami A, Zanon E, Bertomoro A, Gavasso S, Fadin M.

Clin Appl Thromb Hemost. 1999 Apr;5(2):136-8.

PMID:
10725995
27.

Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan.

Bilora F, Dei Rossi C, Girolami B, Casonato A, Zanon E, Bertomoro A, Girolami A.

Clin Appl Thromb Hemost. 1999 Oct;5(4):232-5.

PMID:
10726019
28.

Which assay is the most suitable to investigate von Willebrand factor functional activity?

Casonato A, Pontara E, Bertomoro A, Sartorello F, Girolami A.

Thromb Haemost. 1999 Jun;81(6):994-5. No abstract available.

PMID:
10404785
29.

Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates.

Zanon E, Zerbinati P, Girolami B, Bertomoro A, Girolami A.

Blood Coagul Fibrinolysis. 1999 Apr;10(3):117-20.

PMID:
10357004
30.

Congenital deficiencies and abnormalities of prothrombin.

Girolami A, Scarano L, Saggiorato G, Girolami B, Bertomoro A, Marchiori A.

Blood Coagul Fibrinolysis. 1998 Oct;9(7):557-69. Review.

PMID:
9863703
31.

On the release of von Willebrand factor from endothelial cells after venous occlusion.

Casonato A, Pontara E, Bertomoro A, Zucchetto A, Girolami A.

Thromb Haemost. 1998 Jun;79(6):1216-7. No abstract available.

PMID:
9657453
32.

Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers.

Casonato A, Pontara E, Bertomoro A, Zucchetto S, Zerbinati P, Girolami A.

J Lab Clin Med. 1997 Feb;129(2):251-9.

PMID:
9016863
33.

[Use and misuse of hospital admission in a department of medicine in Padua].

Luzzatto G, Bertomoro A, Cella G, Fabris F, Girolami A.

Epidemiol Prev. 1996 Oct-Dec;20(4):304-12. Italian.

PMID:
9044893
34.

DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.

Casonato A, Dannhauser D, Pontara E, Bertomoro A, Orazi B, Santarossa L, Zerbinati P, Girolami A.

Blood Coagul Fibrinolysis. 1996 Jul;7(5):549-53.

PMID:
8874865
35.

Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.

Casonato A, Pontara E, Bertomoro A, Ossi E, Vincenti M, Girolami A, Borsatti A, Bertaglia G.

Am J Hematol. 1996 Jan;51(1):7-11.

36.

On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease.

Casonato A, Pontara E, Bertomoro A, Zucchetto A, Zerbinati A, Girolami A.

Br J Haematol. 1995 Oct;91(2):512-3. No abstract available.

PMID:
8547104
37.

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors.

Casonato A, Pontara E, Bertomoro A, Dannhauser D, Secchiero S, Zaninotto M, Girolami A.

Ann Hematol. 1995 Oct;71(4):189-94.

PMID:
7578526
38.

Demonstration that venous occlusion fails to release von Willebrand factor multimers.

Casonato A, Pontara E, Bertomoro A, Dannhauser D, Sartori MT, Patrassi G, Boeri G, Girolami A.

Blood Coagul Fibrinolysis. 1995 Sep;6(6):574-8.

PMID:
7578901
39.

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.

Casonato A, Pontara E, Dannhaeuser D, Bertomoro A, Sartori MT, Zerbinati P, Girolami A.

Blood Coagul Fibrinolysis. 1994 Dec;5(6):959-64.

PMID:
7893933
40.

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

Casonato A, Bertomoro A, Pontara E, Dannhauser D, Lazzaro AR, Girolami A.

J Clin Pathol. 1994 Jul;47(7):625-30.

41.

Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy.

Dannhäuser D, Casonato A, Pietrogrande F, Pontara E, Bertomoro A, Zerbinati P, Girolami A.

Acta Haematol. 1994;91(2):73-6.

PMID:
8023647
42.

A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.

Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.

Haematologia (Budap). 1994;26(2):97-109.

PMID:
7890268
43.

First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects.

Girolami A, Pontara E, Dannhauser D, Bertomoro A, Ferasin S, Piccolo M, Casonato A.

Blood Coagul Fibrinolysis. 1993 Feb;4(1):177-81.

PMID:
8457648
44.

Type I Padua: a new variant of von Willebrand's disease.

Casonato A, Pontara E, Dannhauser D, Bertomoro A, Sartori MT, Girolami A.

Br J Haematol. 1992 Aug;81(4):615-6. No abstract available.

PMID:
1390253
45.

Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.

Casonato A, Sartori MT, Pontara E, Bertomoro A, Dannhäuser D, Girolami.

Blood Coagul Fibrinolysis. 1991 Aug;2(4):567-73.

PMID:
1768767
46.

Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease.

Casonato A, Sartori MT, Bertomoro A, Fede T, Vasoin F, Girolami A.

Blood Coagul Fibrinolysis. 1991 Feb;2(1):33-40.

PMID:
1772996

Supplemental Content

Loading ...
Support Center